The smallpox vaccine Vaccinia was successfully used to eradicate smallpox, but although very effective, it was a very reactogenic vaccine and responsible for the deaths of one or two people per million vaccinated. Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivative, also used in the smallpox eradication campaign and now being developed as a recombinant viral vector to produce vaccines against infectious diseases and cancer. Many clinical trials of these n...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Clinical development of Modified Vaccinia virus Ankara vaccines.
If you are the owner of this record, you can report an update to it here: Report update to this record